Addex Therapeutics Ltd. — Form SCHEDULE 13D/A
Filed August 27, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 12/100
What the filing says
This is an amended Schedule 13D/A filed by Timothy Mark Dyer regarding Addex Therapeutics Ltd. on 2026-08-27. The document header and metadata are provided, but the actual substantive disclosure of beneficial ownership changes, share counts, percentages, or transaction details are not included in the text supplied. Without the body of the amendment, no concrete changes can be identified.
Why this rating
Filing metadata only; no substantive ownership or transaction data disclosed in excerpt. Routine SEC amendment filing without material facts visible.
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.